Posts in: investor (2)

Q2 2026 investor update
heltzenpress releaseinvestor
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET todayAugust 20, 2026
NCT process advances beyond original commercial-scale economic targets
press releaseinvestorscienceperrimanNCT
eXoZymes' NCT process achieves 10-fold productivity increase, advancing beyond original commercial-scale economic targetsAugust 18, 2026
EXOZ to host Q2 2026 investor update on Aug 20 @ 5PM Eastern
press releaseinvestor
EXOZ to host Q2 2026 investor update on Aug 20 @ 5PM EasternAugust 11, 2026
Webull 'Biotech Sector' webinar by Perriman
investorpress clippingsvideopodcastperriman
Webull: 'Biotech Sector' webinar by Damien PerrimanJune 30, 2026
EXOZ gets $2 Million NIH Grant to Advance Cannabinoids for Drug Discovery
heltzenpress releaseinvestormedicinesciencecannabinoidskorman
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug DiscoveryJune 24, 2026
Webull Biotech Sector Webinar
investorperriman
CCO of eXoZymes, Perriman, to present at Webull's 'Biotech Sector' webinarJune 18, 2026
$6M fundraise closed
press releaseinvestor
eXoZymes Inc. Announces Closing of $6 Million Public OfferingJune 17, 2026
EXOZ announces pricing of public offering
press releaseinvestor
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and WarrantsJune 8, 2026
Rolling Stone: Next-gen cannabinoids - the innovative race to manufacture compounds
investormedicinepress clippingscannabinoids
Rolling Stone: Next-gen cannabinoids - the innovative race to manufacture compoundsMay 15, 2026
EXOZ investor presentation by Chris Marlett
investorvideo
Updated EXOZ investor presentation by Chris MarlettMay 11, 2026
Previous page
Page 2 of 10
Next page